1,000
Participants
Start Date
January 1, 2024
Primary Completion Date
July 1, 2025
Study Completion Date
January 1, 2026
Inotrope
Vasopressors: Norepinephrine, vasopressin Inotropes: Epinephrine, Dobutamine, Milrinone
Mechanical circulatory support
Intra-aortic balloon pump Extracorporeal membrane oxygenation (ECMO)
anti-bodies
Anti-Dipeptidyl peptidase 3 (DPP3), Anti-Bioactive adrenomedullin (bio-ADM)
St Michael's Hospital, Toronto
Collaborators (1)
University of Helsinki
OTHER
University of Ottawa
OTHER
University of Leipzig
OTHER
University of Nancy
OTHER
McGill University
OTHER
Mayo Clinic
OTHER
University of Paris 5 - Rene Descartes
OTHER
University of Toronto
OTHER
Saint-Louis Hospital, Paris, France
OTHER